As of Feb 12
| 0.00 / 0.00%|
The 1 analysts offering 12-month price forecasts for Artemis Therapeutics Inc have a median target of 175.00, with a high estimate of 175.00 and a low estimate of 175.00. The median estimate represents a +11,566.67% increase from the last price of 1.50.
There are no recommendations available.
Move your mouse over a quarter or year to see how estimates have changed over time.